Company Data

CNS Pharmaceuticals Inc.

Ticker
CNSP
Current Price
$0.075 -10.5%
Market Cap
$4.3M
Price Target
Refer to Report
Volume
35.4M
52wk Range
$0.0803 - $1195
Advanced Market Data

Overview

CNS Pharmaceuticals Inc is a preclinical stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma.

Inbox Intel from Channelchek.

Informed investors make more money. And itā€™s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy